Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep-Oct;28(5):505-506.
doi: 10.1177/12034754241266153. Epub 2024 Jul 26.

Janus Kinase Inhibitor Therapy for Cicatricial Alopecias: An Evidence-Based Review

Affiliations

Janus Kinase Inhibitor Therapy for Cicatricial Alopecias: An Evidence-Based Review

Siddhartha Sood et al. J Cutan Med Surg. 2024 Sep-Oct.
No abstract available

Keywords: JAK inhibitor; Janus kinase inhibitor; central centrifugal cicatricial alopecia; cicatricial alopecia; dissecting cellulitis of the scalp; evidence-based; folliculitis decalvans; frontal fibrosing alopecia; lichen planopilaris; scarring alopecia; systematic review.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting InterestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Dr Asfandyar Mufti has been a speaker for AbbVie and Janssen. Dr Jensen Yeung has been an advisor, consultant, speaker, and/or investigator for AbbVie, Allergan, Amgen, Astellas, Bausche, Baxalta, Boehringer Ingelheim, Celgene, Centocor, Coherus, Dermira, Eli Lilly, Forward, Fresenius Kabi, Galderma, Incyte, Janssen, LEO Pharma, Lilly, Medimmune, Merck, Novartis, Pfizer, Regeneron, Roche, Sanofi Genzyme, Sun Pharma, Takeda, UCB, and Xenon. The remaining authors Mr Sood, Mr Bagit, Ms Seeburruth, Dr Sachdeva, Dr Maliyar, Dr Abduelmula, and Dr Lyvtvn have no relevant disclosures.

LinkOut - more resources